[HTML][HTML] Leptomeningeal carcinomatosis and breast cancer: a systematic review of current evidence on diagnosis, treatment and prognosis

L Mollica, C Leli, S Puglisi, S Sardi, F Sottotetti - Drugs in Context, 2021 - ncbi.nlm.nih.gov
Leptomeningeal carcinomatosis (LC) is a rare but challenging manifestation of advanced
breast cancer with a severe impact on morbidity and mortality. We performed a systematic …

Stereotactic radiosurgery as treatment for brain metastases: an update

I Peña-Pino, CC Chen - Asian journal of neurosurgery, 2023 - thieme-connect.com
Stereotactic radiosurgery (SRS) is a mainstay treatment option for brain metastasis (BM).
While guidelines for SRS use have been outlined by professional societies, consideration of …

Leptomeningeal disease in neurosurgical brain metastases patients: a systematic review and meta-analysis

IA Tewarie, CAC Jessurun… - Neuro-Oncology …, 2021 - academic.oup.com
Background Leptomeningeal disease (LMD) is a complication distinguished by progression
of metastatic disease into the leptomeninges and subsequent spread via cerebrospinal fluid …

Inhibition of Jumonji Histone Demethylases Selectively Suppresses HER2+ Breast Leptomeningeal Carcinomatosis Growth via Inhibition of GMCSF Expression

A Bhan, KI Ansari, MY Chen, R Jandial - Cancer research, 2021 - AACR
HER2+ breast leptomeningeal carcinomatosis (HER2+ LC) occurs when tumor cells spread
to cerebrospinal fluid–containing leptomeninges surrounding the brain and spinal cord, a …

Leptomeningeal metastasis in ER+ HER2-advanced breast cancer patients: a review of the cases in a single institute over a 15-year period

J Watanabe, K Mitsuya, S Nakamoto, H Harada… - Breast Cancer Research …, 2021 - Springer
Purpose While leptomeningeal metastasis (LM) from estrogen receptor-positive, HER2-
negative advanced breast cancer (ER+ HER2-ABC) has a poor prognosis, the details of …

[HTML][HTML] Outcomes in patients with intact and resected brain metastasis treated with 5-fraction stereotactic radiosurgery

DJ Carpenter, AT Fairchild, JD Adamson… - Advances in Radiation …, 2023 - Elsevier
Purpose Hypofractionated stereotactic radiosurgery (HF-SRS) with or without surgical
resection is potentially a preferred treatment for larger or symptomatic brain metastases …

What if: A retrospective reconstruction of resection cavity stereotactic radiosurgery to mimic neoadjuvant stereotactic radiosurgery

G Acker, M Nachbar, N Soffried, B Bodnar… - Frontiers in …, 2023 - frontiersin.org
Introduction Neoadjuvant stereotactic radiosurgery (NaSRS) of brain metastases has gained
importance, but it is not routinely performed. While awaiting the results of prospective …

Clinical determinants impacting overall survival of patients with operable brain metastases from non-small cell lung cancer

A Piffko, B Asey, L Dührsen, I Ristow, J Salamon… - Frontiers in …, 2022 - frontiersin.org
Non-small cell lung cancer (NSCLC) is currently the leading cause of cancer-related death
worldwide, and the incidence of brain metastases (BM) in NSCLC patients is continuously …

Radiotherapy for leptomeningeal carcinomatosis in breast cancer patients: A narrative review

E Pawłowska, A Romanowska, J Jassem - Cancers, 2022 - mdpi.com
Simple Summary Leptomeningeal carcinomatosis (LC) is a rare event in breast cancer (BC)
patients that carries an abysmal prognosis. Little progress has been made in this field in the …

[HTML][HTML] Surgery for Control of Brain Metastases After Previous Checkpoint Inhibitor Immunotherapy

RA Morshed, JE Chung, DD Cummins, V Sudhakar… - World Neurosurgery, 2022 - Elsevier
Background Despite reports on the efficacy of checkpoint inhibitor (CPI) immunotherapies
for metastatic cancers, there are limited data on the effectiveness of surgery for brain …